Boston Scientific

From Wikipedia, the free encyclopedia

Boston Scientific
Type	Public
Founded	1979
Headquarters	Natick, Massachusetts
Key people	John Abele, Founder & Director Peter Nicholas, Founder & Chairman James Tobin, CEO Paul LaViolette, COO

The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific is well known for the development of the Taxus Stent, a drug-coated stent which is used to open clogged arteries.

Boston Scientific's main competitors are Johnson & Johnson and Medtronic. The company recently acquired longtime competitor Guidant for approximately $28 billion. The former Guidant was split between BSC and Abbott Laboratories^[1].

[edit] External links

• The Founder of Boston Scientific Funds a search and recovery of the USS Grunion SS-216 to find his lost father story by NPR

• Boston Scientific official web site.
• Yahoo! - Boston Scientific Corporation Company Profile.
• Company Profile.
• "Gamble wins big at Boston Scientific", boston.com.